TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
VIR

Vir Biotechnology Inc

Healthcare · Biotechnology

10.70$ -0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VIR
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
76.5% 61.5% 78.7% 84.1% 80.0% 89.9% 82.8% 74.5% 51.3%
74.7% 24.8% 21.4% 47.5% 17.8% 30.3% 12.6% 15.9% 23.3%
74.7% 51.4% 74.9% 80.2% 36.2% 85.7% 79.3% 64.7% 46.2%
– – – 0.2% 39.6% 0.9% 0.6% 0.4% 0.4%
0.0% 0.0% – – 0.4% – – – –
2.0% 6.4% 3.2% 2.0% 6.7% 6.7% – – –
6.7% 8.8% 3.3% 1.8% 0.9% 0.6% 0.9% 1.2% 1.7%
14.3% 19.3% 7.0% 3.7% 1.7% 1.2% 1.2% 0.6% 0.8%
127.4% 193.5% 17.2% 22.0% 26.7% 25.8% 17.1% 17.8% 23.7%
4.9% 20.8% 11.6% 10.8% 17.5% 18.2% 9.1% 8.6% 9.3%
0.0% 7.6% 0.0% 0.4% 0.2% 0.1% 0.7% 0.6% 0.9%
1.9% 3.4% 1.1% 0.6% 0.3% 0.2% 0.3% 0.4% 1.0%
0.0% 0.0% – – – – – – –
-27.4% -93.5% 82.8% 78.0% 73.3% 74.2% 82.9% 82.2% 76.3%
-31.0% -101.2% -72.0% -72.6% -7.1% 13.5% -12.4% -54.3% -119.4%
2.8% 50.6% 21.0% 13.0% 6.8% 4.8% 7.0% 9.7% 13.8%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?